A new research centre is advancing cancer treatments by developing and testing RNA therapies that can be tailored to individual patients and tumours. Professor Archa Fox, from UWA’s School of…
The National Centre for Asbestos-Related Diseases (NCARD) is pleased to spotlight Dr Xiao Zhong, a bioinformatician whose expertise is advancing our understanding of cancer immunology through computational analysis. Dr Zhong’s…
The National Centre for Asbestos Related Diseases (NCARD) has been awarded $200,000 from the Medical Research Future Fund (MRFF) to support a new imaging trial for mesothelioma, an asbestos-related cancer.…
The National Centre for Asbestos Related Diseases (NCARD) has been awarded a substantial grant of $500,000 to establish the Mesothelioma AI Genomics and Immunology Consortium (MAGIC). Led by Professor Jenette…
Dr Alistair Cook will use new funding to investigate how low-dose radiotherapy can improve immunotherapy outcomes, with potential benefits for patients who don’t currently respond to treatment. Dr Alistair Cook,…
The 17th International Conference of the International Mesothelioma Interest Group (iMig) will be held in Philadelphia, USA, from October 26 to 29, 2025. With the theme ‘Fostering Global Collaboration,’ this…
The National Centre for Asbestos-Related Diseases (NCARD) is proud to spotlight Faith Hartley, whose journey from honours student to PhD researcher demonstrates a strong commitment to improving cancer treatment. Faith…
We are pleased to welcome Dr Francois Rwandamuriye to NCARD (National Centre for Asbestos Related Diseases) as a Research Associate. His expertise in cancer immunotherapy and drug delivery will strengthen…
Dr Jonathan Chee, a researcher at the National Centre for Asbestos Related Diseases (NCARD), within the University of Western Australia and the Institute of Respiratory Health, has been awarded a…
A groundbreaking study by researchers at the National Centre for Asbestos Related Diseases (NCARD), The Kids Research Institute and the Harry Perkins Institute of Medical Research has identified blood markers…